Hoffmann-La Roche: all 2,744 studies
Page 18 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic TumorsCompletedNCT02794571Phase 1
- Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease ParticipantsCompletedNCT02792179Phase 1
- A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6TerminatedNCT02791256Phase 3
- Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)CompletedNCT02784808
- An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)CompletedNCT02782845Phase 4
- A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced MelanomaCompletedNCT02768207Phase 2
- Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)TerminatedNCT02762383Phase 3
- A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast CancerCompletedNCT02761616
- A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid TumorsCompletedNCT02760797Phase 1
- A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)CompletedNCT02749630Phase 1
- A Study of ERY974 in Patient With Advanced Solid TumorsCompletedNCT02748837Phase 1
- A Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers and Participants With Mild Atopic AsthmaCompletedNCT02748642Phase 1
- A Retrospective, Observational Registry of Participants With Avian Influenza InfectionCompletedNCT02743676
- A Study to Determine the Safety, Tolerability, and Pharmacokinetics of GDC-0310 in Healthy VolunteersCompletedNCT02742779Phase 1
- A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)CompletedNCT02738970Phase 1
- Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) InfectionCompletedNCT02733419Phase 3
- A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)CompletedNCT02723071Phase 1/2
- Study to Investigate the Effect of Formulation and Food on the Pharmacokinetics of GDC-0810CompletedNCT02722018Phase 1
- Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid ArthritisCompletedNCT02721004
- A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)TerminatedNCT02720120Phase 1/2
- A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast CancerCompletedNCT02716792Phase 3
- A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid TumorsCompletedNCT02715531Phase 1
- A Single-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Gantenerumab Following Subcutaneous (SC) Administration in Healthy VolunteersCompletedNCT02711423Phase 1
- Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)CompletedNCT02708732
- Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese AdultsCompletedNCT02706067Phase 4
- Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02699879
- Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy SubjectsCompletedNCT02699710Phase 1
- The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RO6889450 in Healthy VolunteersCompletedNCT02699372Phase 1
- A Study of Prevalence of EGFR Mutations in Participants With NSCLCCompletedNCT02695849
- A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT02693210Phase 2
- Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant RecipientsCompletedNCT02686619Phase 3
- A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac DiseaseCompletedNCT02679014Phase 1
- A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.CompletedNCT02679001
- A Study to Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy VolunteersCompletedNCT02678988Phase 1
- Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)CompletedNCT02674009
- A Study to Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With Chemotherapy Combined With BevacizumabCompletedNCT02673710
- A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic TherapyCompletedNCT02670044Phase 1
- A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in GermanyCompletedNCT02666261
- Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid TumorsCompletedNCT02665416Phase 1
- Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UKCompletedNCT02658747
- A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral SclerosisCompletedNCT02655614Phase 1
- Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in EuropeCompletedNCT02654379
- A Study of the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid TumorsCompletedNCT02650713Phase 1
- Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsActive, not recruitingNCT02650401Phase 1/2
- A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary FibrosisCompletedNCT02648048Phase 1
- EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid ArthritisCompletedNCT02648035
- Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy ParticipantsCompletedNCT02640092Phase 1
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) Given by Mouth in Healthy VolunteersCompletedNCT02633709Phase 1
- A Study to Evaluate Pain, Tolerability, Safety, and Usability of a Single Self-administered Etrolizumab by Auto-injector in Healthy ParticipantsCompletedNCT02629744Phase 1
- Outcomes of FoundationOne Directed Therapy in Cancer of Unknown PrimaryCompletedNCT02628379
- A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)CompletedNCT02627274Phase 1
- A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid MalignancyTerminatedNCT02624141Phase 4
- A Study on Rheumatoid Arthritis Patients Treated With RituximabCompletedNCT02622503
- Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)CompletedNCT02622477
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).CompletedNCT02622334Phase 1
- Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing PotentialCompletedNCT02621957Phase 1
- Concordance Between ctDNA Assay and FoundationOneCompletedNCT02620527
- A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical PracticeTerminatedNCT02616328
- A Study To Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast CancerWithdrawnNCT02616224
- A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC)TerminatedNCT02611310
- Study to Describe Real World Drug Retention Rate of the Tocilizumab at One YearCompletedNCT02608112
- A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal CancerCompletedNCT02608073Phase 2
- A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin BTerminatedNCT02608060Phase 4
- A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady StateCompletedNCT02608034Phase 1
- Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast CancerCompletedNCT02605915Phase 1
- A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or OsteopeniaCompletedNCT02604836Phase 4
- A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)CompletedNCT02604823Phase 4
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B PatientsTerminatedNCT02604355Phase 1
- PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or OsteopeniaCompletedNCT02598453Phase 4
- A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal OsteoporosisCompletedNCT02598440Phase 4
- Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis ConditionCompletedNCT02598167
- A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis BCompletedNCT02598063Phase 4
- A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy VolunteersCompletedNCT02596399Phase 1
- A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast CancerCompletedNCT02595762
- A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)CompletedNCT02593760Phase 1
- Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin ResistanceCompletedNCT02593331Phase 1
- An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing ChemotherapyApproved for marketingNCT02589717
- A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting TransplantationCompletedNCT02586051Phase 1
- A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon CancerCompletedNCT02581423Phase 4
- A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver CancerCompletedNCT02576964Phase 2
- A Bioequivalence Study of Pegylated Interferon Alfa-2a (PEG-IFN Alfa-2a) Benzyl Alcohol (BA)-Free Formulation Versus PEG-IFN Alfa-2a (Pegasys) Following Subcutaneous AdministrationCompletedNCT02573025Phase 1
- A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV)CompletedNCT02570191Phase 4
- A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal AnemiaCompletedNCT02569515Phase 4
- A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) InfectionCompletedNCT02569502Phase 4
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)CompletedNCT02568267Phase 2
- A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal CancerCompletedNCT02567331Phase 4
- A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT02565641Phase 2
- A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in AustraliaCompletedNCT02564770
- A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)CompletedNCT02564614Phase 1
- A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone DiseaseCompletedNCT02564107Phase 4
- A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic MalignanciesCompletedNCT02564094Phase 4
- A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric CancerCompletedNCT02563054Phase 3
- A Study of Ibandronate (Bondronat) in Participants With Malignant Bone DiseaseCompletedNCT02561039Phase 3
- A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric CancerCompletedNCT02560974Phase 3
- A Non-interventional Functional Magnetic Resonance Imaging (fMRI) Study and Behavioral Assessment in Healthy ParticipantsCompletedNCT02560142
- A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT02558140Phase 1
- A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant ParticipantsCompletedNCT02554955Phase 4
- A Study of Epoetin Beta (NeoRecormon) in Participants With Solid TumorsCompletedNCT02554942Phase 4
- An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)CompletedNCT02553850
- A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast CancerCompletedNCT02553707Phase 4